Author/Creator: Lin, Changyi - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Lin, Changyi

1. Cisplatin enhances NK cells immunotherapy efficacy to suppress HCC progression via altering the androgen receptor (AR)-ULBP2 signals. Issue 1 (1st April 2016)

Authors:: Shi, Liang; Lin, Hui; Li, Gonghui; Sun, Yin; Shen, Jiliang; Xu, Junjie; Lin, Changyi; Yeh, Shuyuan; Cai, Xiujun; Chang, Chawnshang
Journal:: Cancer letters
Issue:: Volume 373:Issue 1(2016)
Page Start:: 45
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. ASC-J9® suppresses castration resistant prostate cancer progression via degrading the enzalutamide-induced androgen receptor mutant AR-F876L. Issue 1 (28th August 2016)

Authors:: Wang, Ronghao; Lin, Wanying; Lin, Changyi; Li, Lei; Sun, Yin; Chang, Chawnshang
Journal:: Cancer letters
Issue:: Volume 379:Issue 1(2016)
Page Start:: 154
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. Targeting the androgen receptor (AR) with AR degradation enhancer ASC-J9® led to increase docetaxel sensitivity via suppressing the p21 expression. (1st March 2019)

Authors:: Luo, Jie; Tian, Jing; Chou, FuJu; Lin, Changyi; Xing, Emily Zixin; Zuo, Li; Niu, Yuanjie; Yeh, Shuyuan; Chang, Chawnshang
Journal:: Cancer letters
Issue:: Volume 444(2019)
Page Start:: 35
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗